Globus Medical Shares Race Higher After Better-Than-Expected Q1 Results
Globus Medical Shares Race Higher After Better-Than-Expected Q1 Results
Globus Medical, Inc. (NYSE:GMED) shares are trading higher Wednesday after the company posted better-than-expected first-quarter financial results and raised its fiscal year 2024 guidance.
Globus Medical, Inc.（紐約證券交易所代碼：GMED）股價週三上漲，此前該公司公佈的第一季度財務業績好於預期，並上調了2024財年預期。
The Details:
細節：
Globus Medical reported quarterly earnings of 72 cents per share which beat the analyst consensus estimate of 57 cents by 26.32% and represents a 35.85% increase over earnings from the same period last year.
Globus Medical公佈的季度每股收益爲72美分，比分析師普遍預期的57美分高出26.32％，比去年同期的收益增長了35.85％。
Quarterly sales came in at $606.67 million which beat the analyst consensus estimate by 3.33% and is a 119.26% increase in sales year-over-year.
季度銷售額爲6.0667億美元，比分析師的普遍預期高出3.33％，銷售額同比增長119.26％。
"Since the NuVasive merger closed in September of last year, we worked aggressively to execute our integration strategy and are making significant progress towards rapidly reaching steady state. I am pleased with the first quarter results delivered by strong teamwork and partnership throughout our organization. Surgeons and hospitals are responding favorably to our best-in-class product offering of clinically advanced devices and enabling technologies and worldwide sales reflect the long-term potential of our company," said Dan Scavilla, CEO of Globus Medical.
“自去年9月Nuvasive合併完成以來，我們積極努力執行整合戰略，並在迅速達到穩定狀態方面取得了重大進展。我對整個組織中強大的團隊合作和夥伴關係所帶來的第一季度業績感到滿意。外科醫生和醫院對我們提供臨床先進設備的一流產品反應良好，支持技術和全球銷售反映了我們公司的長期潛力。” Globus Medical首席執行官丹·斯卡維拉說。
Outlook:
展望：
The company updated its guidance for full year 2024 revenue to be in the range of $2.46 billion to $2.485 billion and earnings per share in the range of $2.75 to $2.85. The updated guidance is an increase over the prior full year 2024 revenue guidance of $2.45 billion to $2.475 billion and earnings per share guidance of $2.68 to $2.70.
該公司更新了2024年全年收入的指導方針，使其在24.6億美元至24.85億美元之間，每股收益在27.5美元至2.85美元之間。更新的指引比之前的2024年全年收入預期增加了24.5億美元至24.75億美元，每股收益預期爲268美元至27美元。
Analysts React:
分析師的反應：
Multiple analysts raised their price targets on the stock after the print:
多位分析師在公佈後提高了該股的目標股價：
- BTIG analyst Ryan Zimmerman maintained a Buy rating and raised the price target from $60 to $63.
- Piper Sandler maintained Globus Medical with a Neutral and raised its price target from $55 to $60.
- Stifel analyst Mathew Blackman maintained a Buy rating and raised the price target from $64 to $70.
- BTIG分析師瑞安·齊默爾曼維持買入評級，並將目標股價從60美元上調至63美元。
- 派珀·桑德勒將Globus Medical維持在中性水平，並將其目標股價從55美元上調至60美元。
- Stifel分析師馬修·布萊克曼維持買入評級，並將目標股價從64美元上調至70美元。
Related News: Reddit Shares Soar On First Post-IPO Q1 Results, Strong Q2 Guidance
相關新聞： Reddit 股價因首次公開募股後的第一季度業績和強勁的第二季度指引而飆升
GMED Price Action: According to Benzinga Pro, Globus Medical shares are up 23.6% at $63.50 at the time of publication Wednesday.
GMED價格走勢：根據Benzinga Pro的數據，截至週三發佈時，Globus Medical的股價上漲了23.6％，至63.50美元。
Image: PublicDomainPictures from Pixabay
圖片：來自 Pixabay 的 PublicDomainPic